Pomerantz R A, Eckhauser F E, Knol J A, Guirre K, Raper S E, Turcotte J G
Department of Surgery, University of Michigan Medical Center, Ann Arbor 48109.
Am Surg. 1989 Jun;55(6):333-7.
The importance of "operative timing" in cirrhotic patients with variceal hemorrhage is often underemphasized. To evaluate the effects of immediate versus delayed selective portasystemic decompression on hepatic function, operative mortality, and long-term patient survival, we reviewed the records of 77 patients who underwent distal splenorenal shunts (DSRS) over a 14-year period. A hepatic risk status score was calculated at the time of the index bleed (HRS1) or presentation and again just prior to operation (HRS2). Variables analyzed included age, sex, prior bleeding episodes, time from index bleed to operation, transfusion requirements, and etiology of cirrhosis. Operative mortality rates for immediate versus delayed DSRS were 46.2 per cent and 17 per cent, respectively. HRS improved significantly in elective DSRS patients from 1.46 to 1.30. Predictors of HRS2 included HRS1 and time in days from the index bleed to operation. The most important predictor of early survival for all patients after elective DSRS was the HRS2; however, for patients who underwent elective DSRS and survived, HRS1 was a better predictor of length of survival than HRS2. No other variable analyzed accurately predicted survival. We conclude that HRS can be expected to improve with supportive inhospital therapy; improved HRS at the time of operation is associated with decreased operative mortality; and the extent of liver disease as determined by HRS1 appears to be the chief determinant of long-term patient survival.
“手术时机”在肝硬化静脉曲张出血患者中的重要性常常未得到充分重视。为了评估即刻与延迟选择性门体分流术对肝功能、手术死亡率和患者长期生存率的影响,我们回顾了77例在14年期间接受远端脾肾分流术(DSRS)患者的记录。在首次出血(HRS1)或就诊时以及手术前再次计算肝脏风险状态评分(HRS2)。分析的变量包括年龄、性别、既往出血次数、从首次出血到手术的时间、输血需求以及肝硬化病因。即刻与延迟DSRS的手术死亡率分别为46.2%和17%。择期DSRS患者的HRS从1.46显著改善至1.30。HRS2的预测因素包括HRS1以及从首次出血到手术的天数。择期DSRS后所有患者早期生存的最重要预测因素是HRS2;然而,对于接受择期DSRS且存活的患者,HRS1比HRS2更能预测生存时长。分析的其他变量均不能准确预测生存情况。我们得出结论,预计住院支持治疗可使HRS改善;手术时HRS的改善与手术死亡率降低相关;HRS1所确定的肝病程度似乎是患者长期生存的主要决定因素。